Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1293|19|3|184-194

ISSN： 1464-2662

Source： HIV MEDICINE, Vol.19, Iss.3, 2018-03, pp. : 184-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada

By  

HIV MEDICINE, Vol. 16, Iss. 6, 2015-07 ,pp. : 337-345

John Wiley & Sons Inc

Access to resources Recommend Favorite

Body mass index and early CD4 T‐cell recovery among adults initiating antiretroviral therapy in North America, 1998–2010

By  

HIV MEDICINE, Vol. 16, Iss. 9, 2015-10 ,pp. : 572-577

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD4 count monitoring seldom contributes to clinical‐decision making

By  

HIV MEDICINE, Vol. 16, Iss. 3, 2015-03 ,pp. : 196-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

T cell apoptosis in HIV-infected patients with incomplete immune recovery after antiretroviral therapy

By Saidakova E.   Korolevskaya L.   Shmagel N.   Shmagel K.   Chereshnev V.  

Doklady Biological Sciences, Vol. 450, Iss. 1, 2013-05 ,pp. : 189-191

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 3, 2018-03 ,pp. : 518-525

John Wiley & Sons Inc

Access to resources Recommend Favorite